Differences in GFR and Tissue Oxygenation, and Interactions between Stenotic and Contralateral Kidneys in Unilateral Atherosclerotic Renovascular Disease.
暂无分享,去创建一个
L. Lerman | J. Glockner | Hui Tang | S. Textor | M. Mckusick | S. Misra | S. Herrmann | A. Saad | A. Eirin | J. Woollard | H. Tang
[1] L. Lerman,et al. Paradigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now? , 2015, Journal of the American Society of Nephrology : JASN.
[2] M. Stegall,et al. Compensatory Hypertrophy of the Remaining Kidney in Medically Complex Living Kidney Donors Over the Long Term , 2015, Transplantation.
[3] L. Lerman,et al. Assessment of Renal Artery Stenosis Using Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging Analysis , 2014, Investigative radiology.
[4] Haixin Hong,et al. Neutrophil gelatinase-associated lipocalin protects renal tubular epithelial cells in hypoxia–reperfusion by reducing apoptosis , 2014, International Urology and Nephrology.
[5] Ralph B D'Agostino,et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.
[6] L. Juncos,et al. Interaction Between Stenotic and Contralateral Kidneys: Unique Features of Each in Unilateral Disease , 2014 .
[7] L. Lerman,et al. Human renovascular disease: estimating fractional tissue hypoxia to analyze blood oxygen level-dependent MR. , 2013, Radiology.
[8] L. Lerman,et al. Stent Revascularization Restores Cortical Blood Flow and Reverses Tissue Hypoxia in Atherosclerotic Renal Artery Stenosis but Fails to Reverse Inflammatory Pathways or Glomerular Filtration Rate , 2013, Circulation. Cardiovascular interventions.
[9] L. Lerman,et al. TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[10] L. Lerman,et al. Inflammatory and injury signals released from the post-stenotic human kidney. , 2013, European heart journal.
[11] W. Yuan,et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) May Play a Protective Role Against Rats Ischemia/Reperfusion Renal Injury via Inhibiting Tubular Epithelial Cell Apoptosis , 2013, Renal Failure.
[12] A. Rule,et al. Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] Hwang Gyun Jeon,et al. Predictors of kidney volume change and delayed kidney function recovery after donor nephrectomy. , 2010, The Journal of urology.
[14] L. Lerman,et al. Preserved Oxygenation Despite Reduced Blood Flow in Poststenotic Kidneys in Human Atherosclerotic Renal Artery Stenosis , 2010, Hypertension.
[15] S. Theocharis,et al. Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis , 2010, Clinical chemistry and laboratory medicine.
[16] C. Baigent,et al. Revascularization versus medical therapy for renal-artery stenosis. , 2009, The New England journal of medicine.
[17] L. Lerman,et al. Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. , 2009, Progress in cardiovascular diseases.
[18] R. Lavi,et al. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension , 2009, Journal of hypertension.
[19] L. Lerman,et al. Comparison of 1.5 and 3 T BOLD MR to Study Oxygenation of Kidney Cortex and Medulla in Human Renovascular Disease , 2009, Investigative radiology.
[20] C. White,et al. Ultrasound velocity criteria for renal in-stent restenosis. , 2009, Journal of vascular surgery.
[21] W. Mali,et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. , 2009, Annals of internal medicine.
[22] D. Ovcharenko,et al. Neutrophil gelatinase-associated lipocalin as a survival factor. , 2005, The Biochemical journal.
[23] R. D'Agostino,et al. The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. , 2005, Journal of vascular and interventional radiology : JVIR.
[24] C. Napoli,et al. Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia. , 2003, Kidney international.
[25] G. Chatellier,et al. Proteinuria in renal artery occlusion is related to active renin concentration and contralateral kidney size , 2002, Journal of hypertension.
[26] E. Ritman,et al. Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function. , 2001, American journal of physiology. Renal physiology.
[27] T. Larson,et al. GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[28] J. Laragh,et al. Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. , 1973, The American journal of medicine.
[29] J. Laragh,et al. The physiology of renin secretion in essential hypertension. Estimation of renin secretion rate and renal plasma flow from peripheral and renal vein renin levels. , 1973, The American journal of medicine.
[30] H. Goldblatt,et al. STUDIES ON EXPERIMENTAL HYPERTENSION I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA , 1934 .